185 related articles for article (PubMed ID: 29196360)
1. The use of panel testing in familial breast and ovarian cancer.
Prapa M; Solomons J; Tischkowitz M
Clin Med (Lond); 2017 Dec; 17(6):568-572. PubMed ID: 29196360
[TBL] [Abstract][Full Text] [Related]
2. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
3. Practical aspects of genetic counseling in breast cancer: lights and shadows.
Christinat A; Pagani O
Breast; 2013 Aug; 22(4):375-82. PubMed ID: 23673076
[TBL] [Abstract][Full Text] [Related]
4. [Familial breast cancer, ovarian cancer].
Inoue M
Nihon Rinsho; 2006 Jun; Suppl 2():366-70. PubMed ID: 16817423
[No Abstract] [Full Text] [Related]
5. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
Stuckey AR; Onstad MA
Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
[TBL] [Abstract][Full Text] [Related]
6. Translational advances regarding hereditary breast cancer syndromes.
Gage M; Wattendorf D; Henry LR
J Surg Oncol; 2012 Apr; 105(5):444-51. PubMed ID: 22441895
[TBL] [Abstract][Full Text] [Related]
7. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
[TBL] [Abstract][Full Text] [Related]
8. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
[TBL] [Abstract][Full Text] [Related]
9. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
10. Hereditary gastrointestinal cancer.
Hata K; Yamamoto Y; Kiyomatsu T; Tanaka T; Kazama S; Nozawa H; Kawai K; Tanaka J; Nishikawa T; Otani K; Yasuda K; Kishikawa J; Nagai Y; Anzai H; Shinagawa T; Arakawa K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
Surg Today; 2016 Oct; 46(10):1115-22. PubMed ID: 26676416
[TBL] [Abstract][Full Text] [Related]
11. Hereditary cancer syndromes as model systems for chemopreventive agent development.
Walcott FL; Patel J; Lubet R; Rodriguez L; Calzone KA
Semin Oncol; 2016 Feb; 43(1):134-145. PubMed ID: 26970132
[TBL] [Abstract][Full Text] [Related]
12. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Bonache S; Esteban I; Moles-Fernández A; Tenés A; Duran-Lozano L; Montalban G; Bach V; Carrasco E; Gadea N; López-Fernández A; Torres-Esquius S; Mancuso F; Caratú G; Vivancos A; Tuset N; Balmaña J; Gutiérrez-Enríquez S; Diez O
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2495-2513. PubMed ID: 30306255
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
15. Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes.
Wang Q
Acta Pharmacol Sin; 2016 Feb; 37(2):143-9. PubMed ID: 26616728
[TBL] [Abstract][Full Text] [Related]
16. Beyond BRCA1 and BRCA2.
King-Spohn K; Pilarski R
Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
[TBL] [Abstract][Full Text] [Related]
17. Hereditary breast cancer: the era of new susceptibility genes.
Apostolou P; Fostira F
Biomed Res Int; 2013; 2013():747318. PubMed ID: 23586058
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
19. Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel.
Kwong A; Shin VY; Au CH; Law FB; Ho DN; Ip BK; Wong AT; Lau SS; To RM; Choy G; Ford JM; Ma ES; Chan TL
J Mol Diagn; 2016 Jul; 18(4):580-94. PubMed ID: 27157322
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]